PARAGARD Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paragard, and when can generic versions of Paragard launch?
Paragard is a drug marketed by Coopersurgical and is included in one NDA.
The generic ingredient in PARAGARD is copper. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the copper profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PARAGARD?
- What are the global sales for PARAGARD?
- What is Average Wholesale Price for PARAGARD?
Summary for PARAGARD
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for PARAGARD |
| DailyMed Link: | PARAGARD at DailyMed |
US Patents and Regulatory Information for PARAGARD
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Coopersurgical | PARAGARD T 380A | copper | SYSTEM;INTRAUTERINE | 018680-001 | Nov 15, 1984 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
